ASX - By Stock
|
BIT |
Re:
Ann: $1.4M R&D Tax Rebate
|
|
Evansblue12
|
52 |
15K |
3 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
52
|
15K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: $1.4M R&D Tax Rebate
|
|
Evansblue12
|
52 |
15K |
12 |
04/05/21 |
04/05/21 |
ASX - By Stock
|
52
|
15K
|
12
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities Report
|
|
Evansblue12
|
31 |
9.1K |
19 |
29/04/21 |
29/04/21 |
ASX - By Stock
|
31
|
9.1K
|
19
|
|
ASX - By Stock
|
BIT |
Re:
Announcement ? this week ?
|
|
Evansblue12
|
2 |
1.1K |
1 |
26/04/21 |
26/04/21 |
ASX - By Stock
|
2
|
1.1K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Evansblue12
|
13K |
6.3M |
2 |
21/04/21 |
21/04/21 |
ASX - By Stock
|
13K
|
6.3M
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Evansblue12
|
13K |
6.3M |
4 |
20/04/21 |
20/04/21 |
ASX - By Stock
|
13K
|
6.3M
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Without a hope
|
|
Evansblue12
|
553 |
167K |
3 |
19/04/21 |
19/04/21 |
ASX - By Stock
|
553
|
167K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Without a hope
|
|
Evansblue12
|
553 |
167K |
2 |
13/04/21 |
13/04/21 |
ASX - By Stock
|
553
|
167K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Without a hope
|
|
Evansblue12
|
553 |
167K |
2 |
08/04/21 |
08/04/21 |
ASX - By Stock
|
553
|
167K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Without a hope
|
|
Evansblue12
|
553 |
167K |
0 |
07/04/21 |
07/04/21 |
ASX - By Stock
|
553
|
167K
|
0
|
|
ASX - By Stock
|
BIT |
Re:
Without a hope
|
|
Evansblue12
|
553 |
167K |
6 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
553
|
167K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Without a hope
|
|
Evansblue12
|
553 |
167K |
3 |
06/04/21 |
06/04/21 |
ASX - By Stock
|
553
|
167K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
Evansblue12
|
3.2K |
1.0M |
0 |
31/03/21 |
31/03/21 |
ASX - By Stock
|
3.2K
|
1.0M
|
0
|
|
ASX - By Stock
|
BIT Medicine |
Re:
Published Papers
|
|
Evansblue12
|
228 |
69K |
6 |
30/03/21 |
30/03/21 |
ASX - By Stock
|
228
|
69K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Lead Series for SARS-COV-2 Program
|
|
Evansblue12
|
115 |
44K |
12 |
16/03/21 |
16/03/21 |
ASX - By Stock
|
115
|
44K
|
12
|
|
ASX - By Stock
|
BIT Medicine |
Re:
Published Papers
|
|
Evansblue12
|
228 |
69K |
1 |
11/03/21 |
11/03/21 |
ASX - By Stock
|
228
|
69K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Without a hope
|
|
Evansblue12
|
553 |
167K |
2 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
553
|
167K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Without a hope
|
|
Evansblue12
|
553 |
167K |
2 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
553
|
167K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Without a hope
|
|
Evansblue12
|
553 |
167K |
6 |
10/03/21 |
10/03/21 |
ASX - By Stock
|
553
|
167K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Half Yearly Report and Accounts
|
|
Evansblue12
|
220 |
64K |
2 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
220
|
64K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Half Yearly Report and Accounts
|
|
Evansblue12
|
220 |
64K |
3 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
220
|
64K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Half Yearly Report and Accounts
|
|
Evansblue12
|
220 |
64K |
1 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
220
|
64K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Half Yearly Report and Accounts
|
|
Evansblue12
|
220 |
64K |
1 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
220
|
64K
|
1
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Half Yearly Report and Accounts
|
|
Evansblue12
|
220 |
64K |
6 |
24/02/21 |
24/02/21 |
ASX - By Stock
|
220
|
64K
|
6
|
|
ASX - By Stock
|
BIT Medicine |
Re:
Published Papers
|
|
Evansblue12
|
228 |
69K |
0 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
228
|
69K
|
0
|
|
ASX - By Stock
|
BIT Medicine |
Re:
Published Papers
|
|
Evansblue12
|
228 |
69K |
0 |
23/02/21 |
23/02/21 |
ASX - By Stock
|
228
|
69K
|
0
|
|
ASX - By Stock
|
BIT Medicine |
Re:
Published Papers
|
|
Evansblue12
|
228 |
69K |
4 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
228
|
69K
|
4
|
|
ASX - By Stock
|
BIT Medicine |
Re:
Published Papers
|
|
Evansblue12
|
228 |
69K |
4 |
22/02/21 |
22/02/21 |
ASX - By Stock
|
228
|
69K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
BIT036- a likely candidate for curing COVID-19
|
|
Evansblue12
|
2.0K |
723K |
4 |
18/02/21 |
18/02/21 |
ASX - By Stock
|
2.0K
|
723K
|
4
|
|
ASX - By Stock
|
BIT |
Re:
Without a hope
|
|
Evansblue12
|
553 |
167K |
6 |
15/02/21 |
15/02/21 |
ASX - By Stock
|
553
|
167K
|
6
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities Report
|
|
Evansblue12
|
48 |
12K |
3 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
48
|
12K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities Report
|
|
Evansblue12
|
48 |
12K |
2 |
29/01/21 |
29/01/21 |
ASX - By Stock
|
48
|
12K
|
2
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Evansblue12
|
13K |
6.3M |
1 |
14/01/21 |
14/01/21 |
ASX - By Stock
|
13K
|
6.3M
|
1
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Evansblue12
|
13K |
6.3M |
5 |
29/12/20 |
29/12/20 |
ASX - By Stock
|
13K
|
6.3M
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Biotron Compounds Show Activity Against SARS-CoV-2 Virus
|
|
Evansblue12
|
440 |
141K |
2 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
440
|
141K
|
2
|
|
ASX - By Stock
|
TLG |
Re:
TLG Chart
|
|
Evansblue12
|
3.7K |
1.3M |
5 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
3.7K
|
1.3M
|
5
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron BIT COVID19
|
|
Evansblue12
|
368 |
119K |
5 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
368
|
119K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Biotron Compounds Show Activity Against SARS-CoV-2 Virus
|
|
Evansblue12
|
440 |
141K |
2 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
440
|
141K
|
2
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron BIT COVID19
|
|
Evansblue12
|
368 |
119K |
2 |
09/12/20 |
09/12/20 |
ASX - By Stock
|
368
|
119K
|
2
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron BIT COVID19
|
|
Evansblue12
|
368 |
119K |
3 |
24/11/20 |
24/11/20 |
ASX - By Stock
|
368
|
119K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Evansblue12
|
13K |
6.3M |
4 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
13K
|
6.3M
|
4
|
|
ASX - By Stock
|
BIT |
Re:
$10 Billion Deal
|
|
Evansblue12
|
13K |
6.3M |
13 |
16/11/20 |
16/11/20 |
ASX - By Stock
|
13K
|
6.3M
|
13
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Biotron Compounds Show Activity Against SARS-CoV-2 Virus
|
|
Evansblue12
|
440 |
141K |
1 |
13/11/20 |
13/11/20 |
ASX - By Stock
|
440
|
141K
|
1
|
|
ASX - By Stock
|
BIT Biotech |
Re:
Biotron BIT COVID19
|
|
Evansblue12
|
368 |
119K |
3 |
10/11/20 |
10/11/20 |
ASX - By Stock
|
368
|
119K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities Report
|
|
Evansblue12
|
53 |
12K |
5 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
53
|
12K
|
5
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities Report
|
|
Evansblue12
|
53 |
12K |
3 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
53
|
12K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: Quarterly Activities Report
|
|
Evansblue12
|
53 |
12K |
3 |
29/10/20 |
29/10/20 |
ASX - By Stock
|
53
|
12K
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Ann: BIT225 HIV-1 Immunomodulatory Paper Published
|
|
Evansblue12
|
46 |
18K |
9 |
15/10/20 |
15/10/20 |
ASX - By Stock
|
46
|
18K
|
9
|
|
ASX - By Stock
|
BIT |
Re:
chart daily
|
|
Evansblue12
|
3.2K |
1.0M |
3 |
01/10/20 |
01/10/20 |
ASX - By Stock
|
3.2K
|
1.0M
|
3
|
|
ASX - By Stock
|
BIT |
Re:
Bill Gates &MG Foundation &BIOTRON
|
|
Evansblue12
|
294 |
88K |
1 |
23/09/20 |
23/09/20 |
ASX - By Stock
|
294
|
88K
|
1
|
|